These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 27667276)

  • 1. [The effect and factors associated with outcome of extracorporeal membrane oxygenation in refractory cardiogenic shock patients].
    Zhu RQ; Liu CZ; Lu JH; Su YP; Wen SC; Nie GJ; Hu YZ; Zuo LE
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):777-781. PubMed ID: 27667276
    [No Abstract]   [Full Text] [Related]  

  • 2. A rationale for early extracorporeal membrane oxygenation in patients with postinfarction ventricular septal rupture complicated by cardiogenic shock.
    Rob D; Špunda R; Lindner J; Rohn V; Kunstýř J; Balík M; Rulíšek J; Kopecký P; Lipš M; Šmíd O; Kovárník T; Mlejnský F; Linhart A; Bělohlávek J
    Eur J Heart Fail; 2017 May; 19 Suppl 2():97-103. PubMed ID: 28470920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical application of extracorporeal membrane oxygenation for treatment of adult refractory cardiogenic shock].
    Hou LS; Xie G; Li JW; Jiang CH; Yuan Y; Li BF; Jiang HM; Ning Y; Wu GS; Zheng WH; Zhao SB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jul; 41(7):590-3. PubMed ID: 24284188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of oxygen challenge test for patients with cardiogenic shock receiving extracorporeal membrane oxygenation].
    Dong L; Zhang X; Liang F; Yu X; Yang T; Li L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Dec; 29(12):1102-1106. PubMed ID: 29216944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VA-ECMO Support in Nonsurgical Patients With Refractory Cardiogenic Shock: Pre-Implant Outcome Predictors.
    Fux T; Holm M; Corbascio M; Lund LH; van der Linden J
    Artif Organs; 2019 Feb; 43(2):132-141. PubMed ID: 30402887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: a retrospective study of the Extracorporeal Life Support Organizations' ECMO case registry.
    Weiner L; Mazzeffi MA; Hines EQ; Gordon D; Herr DL; Kim HK
    Clin Toxicol (Phila); 2020 Jul; 58(7):705-710. PubMed ID: 31617764
    [No Abstract]   [Full Text] [Related]  

  • 7. Extracorporeal membrane oxygenation support in refractory cardiogenic shock: treatment strategies and analysis of risk factors.
    Loforte A; Marinelli G; Musumeci F; Folesani G; Pilato E; Martin Suarez S; Montalto A; Lilla Della Monica P; Grigioni F; Frascaroli G; Menichetti A; Di Bartolomeo R; Arpesella G
    Artif Organs; 2014 Jul; 38(7):E129-41. PubMed ID: 24841637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes in patients after extracorporeal membrane oxygenation support for post-cardiotomy cardiogenic shock: a single-centre experience of 92 cases.
    Guihaire J; Dang Van S; Rouze S; Rosier S; Roisne A; Langanay T; Corbineau H; Verhoye JP; Flécher E
    Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):363-369. PubMed ID: 28575211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Veno-arterial extracorporeal membrane oxygenation for short-term mechanical circulation support in adults with cardiogenic shock: a single centre experience.
    Musiał R; Moncznik P; Śmiałek P; Stoliński J; Sadowski J; Drwiła R
    Kardiol Pol; 2016; 74(12):1477-1484. PubMed ID: 27221960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictors of in-hospital mortality in adult postcardiotomy cardiacgenic shock patients successfully weaned from venoarterial extracorporeal membrane oxygenation].
    Xie HX; Yang F; Jiang CJ; Wang JH; Hou DB; Wang JG; Wang H; Hou XT
    Zhonghua Yi Xue Za Zhi; 2017 Mar; 97(12):929-933. PubMed ID: 28355755
    [No Abstract]   [Full Text] [Related]  

  • 11. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score.
    Schmidt M; Burrell A; Roberts L; Bailey M; Sheldrake J; Rycus PT; Hodgson C; Scheinkestel C; Cooper DJ; Thiagarajan RR; Brodie D; Pellegrino V; Pilcher D
    Eur Heart J; 2015 Sep; 36(33):2246-56. PubMed ID: 26033984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock.
    Ko WJ; Lin CY; Chen RJ; Wang SS; Lin FY; Chen YS
    Ann Thorac Surg; 2002 Feb; 73(2):538-45. PubMed ID: 11845871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Myocardial Infarction Complicated by Cardiogenic Shock: An Algorithm-Based Extracorporeal Membrane Oxygenation Program Can Improve Clinical Outcomes.
    Unai S; Tanaka D; Ruggiero N; Hirose H; Cavarocchi NC
    Artif Organs; 2016 Mar; 40(3):261-9. PubMed ID: 26148217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical cardiopulmonary support for refractory cardiogenic shock.
    Reedy JE; Swartz MT; Raithel SC; Szukalski EA; Pennington DG
    Heart Lung; 1990 Sep; 19(5 Pt 1):514-23. PubMed ID: 2211160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outcome of extracorporeal membrane oxygenation support for adult patients in Fuwai Hospital during the last 10 years: treatment strategy and risk factors].
    Guodong G; Lin L; Qiang H; Jinxiao H; Feilong H; Bingyan J; Liu jinping ; Kun Y; Cun L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Dec; 27(12):959-64. PubMed ID: 27318337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal membrane oxygenation for refractory cardiogenic shock after cardiac surgery: predictors of early mortality and outcome from 51 adult patients.
    Hsu PS; Chen JL; Hong GJ; Tsai YT; Lin CY; Lee CY; Chen YG; Tsai CS
    Eur J Cardiothorac Surg; 2010 Feb; 37(2):328-33. PubMed ID: 19748279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation.
    Asaumi Y; Yasuda S; Morii I; Kakuchi H; Otsuka Y; Kawamura A; Sasako Y; Nakatani T; Nonogi H; Miyazaki S
    Eur Heart J; 2005 Oct; 26(20):2185-92. PubMed ID: 16014643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmia-induced cardiomyopathy: A potentially reversible cause of refractory cardiogenic shock requiring venoarterial extracorporeal membrane oxygenation.
    Hékimian G; Paulo N; Waintraub X; Bréchot N; Schmidt M; Lebreton G; Pineton de Chambrun M; Muller G; Franchineau G; Bourcier S; Nieszkowska A; Masi P; Leprince P; Combes A; Gandjbakhch E; Luyt CE
    Heart Rhythm; 2021 Jul; 18(7):1106-1112. PubMed ID: 33722763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience and result of extracorporeal membrane oxygenation in treating fulminant myocarditis with shock: what mechanical support should be considered first?
    Chen YS; Yu HY; Huang SC; Chiu KM; Lin TY; Lai LP; Lin FY; Wang SS; Chu SH; Ko WJ
    J Heart Lung Transplant; 2005 Jan; 24(1):81-7. PubMed ID: 15653384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety research of extracorporeal membrane oxygenation treatment on cardiogenic shock: a multicenter clinical study.
    Hou G; Yu K; Yin X; Wang H; Xu W; Du Z; Hou X; Long Y; Chen H; Xu L; Liu S
    Minerva Cardioangiol; 2016 Apr; 64(2):121-6. PubMed ID: 26080684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.